ETtechWellness and longevity startup Biopeak has raised $3 million in seed funding from Claypond Capital, the family office of Manipal Group chairman Ranjan Pai, Accel India cofounder Prashanth Prakash, and existing investor Rainmatter, the investment arm of Zerodha.
The Bengaluru-based company offers personalised health services through its own clinics, using advanced diagnostics and artificial intelligence (AI) to predict health risks and tailor treatment programmes. It began serving clients in late March 2025.
“We offer solutions that are predictive, not reactive,” said cofounder and CEO Rishi Pardal.
Biopeak’s diagnostic protocol includes lab tests, MRI and CT scans, and non-invasive evaluations to assess the health of a person’s organ systems. Based on these results, the company creates a comprehensive health programme for each client.
The startup will use the fresh capital to deepen its scientific research, scale its AI platform, and expand its clinic network. It opened its first longevity clinic in Bengaluru earlier this year and plans to launch centres across other major metros over the next year.
According to startup data platform Tracxn, Biopeak had previously raised $1.43 million in angel funding from Zerodha’s Nikhil Kamath in August 2024.
Biopeak targets two core client groups: performance-oriented individuals such as athletes and health-conscious users, and people with unresolved or chronic symptoms, like irritable bowel syndrome (IBS), which traditional medicine has struggled to address. The diagnostic process is led by human experts.
To adapt its healthspan protocols to South Asian populations, the startup has partnered with research institutions including the Indian Institute of Science (IISc) and Longevity India, a scientific forum focused on ageing biology. Prakash is a founding patron of the forum.
“There are lifestyle-related interventions in all diseases, but today, there are breakthroughs in cellular technology and AI-led diagnostics which aren’t widely accessible,” Prakash said.
He added that the next phase of healthcare—Medicine 4.0—will rely on integrating IoT and AI into personalised medical practices.
“Medicine 4.0 aims to record individual health indicators, detect dysfunctions before symptoms emerge, and deliver interventions based on a person’s unique biology and environment. This requires a new model of care—like the concierge clinics Biopeak is building,” he told ET.
He explained that the shift is based on a deeper molecular and cellular understanding of health. Unlike conventional blood markers that signal disease only after onset, AI-led diagnostics can predict a person’s disease trajectory—such as whether they are one or four years away from developing prediabetes.
Each Biopeak client undergoes more than six hours of multidisciplinary consultation. The company also offers specialised modules focused on women’s health, gut and skin longevity, and advanced imaging for early-stage degeneration.
The longevity and wellness sector is gaining traction in India, with startups exploring both research-driven and service-led models for healthy ageing. In October 2024, Zomato founder and CEO Deepinder Goyal launched a personal venture, Continue, aimed at performance optimisation and wellness tracking. Meanwhile, IISc partnered with Rainmatter in December 2024 to launch an entrepreneur-in-residence programme focused on deep science and tech in the space.
The Bengaluru-based company offers personalised health services through its own clinics, using advanced diagnostics and artificial intelligence (AI) to predict health risks and tailor treatment programmes. It began serving clients in late March 2025.
“We offer solutions that are predictive, not reactive,” said cofounder and CEO Rishi Pardal.
Biopeak’s diagnostic protocol includes lab tests, MRI and CT scans, and non-invasive evaluations to assess the health of a person’s organ systems. Based on these results, the company creates a comprehensive health programme for each client.
The startup will use the fresh capital to deepen its scientific research, scale its AI platform, and expand its clinic network. It opened its first longevity clinic in Bengaluru earlier this year and plans to launch centres across other major metros over the next year.
According to startup data platform Tracxn, Biopeak had previously raised $1.43 million in angel funding from Zerodha’s Nikhil Kamath in August 2024.
Discover the stories of your interest
Biopeak targets two core client groups: performance-oriented individuals such as athletes and health-conscious users, and people with unresolved or chronic symptoms, like irritable bowel syndrome (IBS), which traditional medicine has struggled to address. The diagnostic process is led by human experts.
To adapt its healthspan protocols to South Asian populations, the startup has partnered with research institutions including the Indian Institute of Science (IISc) and Longevity India, a scientific forum focused on ageing biology. Prakash is a founding patron of the forum.
“There are lifestyle-related interventions in all diseases, but today, there are breakthroughs in cellular technology and AI-led diagnostics which aren’t widely accessible,” Prakash said.
He added that the next phase of healthcare—Medicine 4.0—will rely on integrating IoT and AI into personalised medical practices.
“Medicine 4.0 aims to record individual health indicators, detect dysfunctions before symptoms emerge, and deliver interventions based on a person’s unique biology and environment. This requires a new model of care—like the concierge clinics Biopeak is building,” he told ET.
He explained that the shift is based on a deeper molecular and cellular understanding of health. Unlike conventional blood markers that signal disease only after onset, AI-led diagnostics can predict a person’s disease trajectory—such as whether they are one or four years away from developing prediabetes.
Each Biopeak client undergoes more than six hours of multidisciplinary consultation. The company also offers specialised modules focused on women’s health, gut and skin longevity, and advanced imaging for early-stage degeneration.
The longevity and wellness sector is gaining traction in India, with startups exploring both research-driven and service-led models for healthy ageing. In October 2024, Zomato founder and CEO Deepinder Goyal launched a personal venture, Continue, aimed at performance optimisation and wellness tracking. Meanwhile, IISc partnered with Rainmatter in December 2024 to launch an entrepreneur-in-residence programme focused on deep science and tech in the space.
ETPrime Membership
